BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36098904)

  • 1. Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer.
    Jiang Z; Wei C; Luo Y; Xiao Y; Wang L; Guo W; Yuan X
    J Clin Lab Anal; 2022 Oct; 36(10):e24692. PubMed ID: 36098904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.
    Khoja S; Nitzahn M; Hermann K; Truong B; Borzone R; Willis B; Rudd M; Palmer DJ; Ng P; Brunetti-Pierri N; Lipshutz GS
    Mol Genet Metab; 2018 Aug; 124(4):243-253. PubMed ID: 29801986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the therapeutic potential of carbamoyl phosphate synthetase 1 (CPS1) in human diseases.
    Zhang L; Zou Y; Lu Y; Li Z; Gao F
    Bioorg Chem; 2023 Jan; 130():106253. PubMed ID: 36356370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamyl phosphate synthetase I. A novel marker for gastric carcinoma.
    Liu TH; Li DC; Gu CF; Ye SF
    Chin Med J (Engl); 1989 Aug; 102(8):630-8. PubMed ID: 2517620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
    Laemmle A; Hahn D; Hu L; Rüfenacht V; Gautschi M; Leibundgut K; Nuoffer JM; Häberle J
    Mol Genet Metab; 2015 Mar; 114(3):438-44. PubMed ID: 25639153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency.
    Choi Y; Oh A; Lee Y; Kim GH; Choi JH; Yoo HW; Lee BH
    Clin Chim Acta; 2022 Feb; 526():55-61. PubMed ID: 34973183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoosmosis alters hepatocyte mitochondrial morphology and induces selective release of carbamoyl phosphate synthetase 1.
    Li P; Kuo N; Patel R; Omary MB
    Am J Physiol Gastrointest Liver Physiol; 2023 Oct; 325(4):G334-G346. PubMed ID: 37489865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
    Kim J; Hu Z; Cai L; Li K; Choi E; Faubert B; Bezwada D; Rodriguez-Canales J; Villalobos P; Lin YF; Ni M; Huffman KE; Girard L; Byers LA; Unsal-Kacmaz K; Peña CG; Heymach JV; Wauters E; Vansteenkiste J; Castrillon DH; Chen BPC; Wistuba I; Lambrechts D; Xu J; Minna JD; DeBerardinis RJ
    Nature; 2017 Jun; 546(7656):168-172. PubMed ID: 28538732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer.
    Jiang Z; Zhang C; Gan L; Jia Y; Xiong Y; Chen Y; Wang Z; Wang L; Luo H; Li J; Zhu R; Ji X; Yu Q; Wang L
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800038. PubMed ID: 30485682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of citrulline substitution on clinical outcome after liver transplantation in carbamoyl phosphate synthetase 1 and ornithine transcarbamylase deficiency.
    Aldrian D; Waldner B; Vogel GF; El-Gharbawy AH; McKiernan P; Vockley J; Landau YE; Al Mutairi F; Stepien KM; Kwok AM; Yıldız Y; Honzik T; Kelifova S; Ellaway C; Lund AM; Mori M; Grünert SC; Scholl-Bürgi S; Zöggeler T; Oberhuber R; Schneeberger S; Müller T; Karall D
    J Inherit Metab Dis; 2024 Mar; 47(2):220-229. PubMed ID: 38375550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis.
    de Cima S; Polo LM; Díez-Fernández C; Martínez AI; Cervera J; Fita I; Rubio V
    Sci Rep; 2015 Nov; 5():16950. PubMed ID: 26592762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y-box binding protein-1 down-regulates expression of carbamoyl phosphate synthetase-I by suppressing CCAAT enhancer-binding protein-alpha function in mice.
    Chen YR; Sekine K; Nakamura K; Yanai H; Tanaka M; Miyajima A
    Gastroenterology; 2009 Jul; 137(1):330-40. PubMed ID: 19272383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
    Zhang S; Hu Y; Wu Z; Zhou X; Wu T; Li P; Lian Q; Xu S; Gu J; Chen L; Wu G; Zhang T; Tang J; Xue J
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1244-1256. PubMed ID: 36423742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
    Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
    J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of carbamoyl phosphate synthetase 1 (CPS1) deficiency in Turkish patients: characterization of a founder mutation by use of recombinant CPS1 from insect cells expression.
    Hu L; Diez-Fernandez C; Rüfenacht V; Hismi BÖ; Ünal Ö; Soyucen E; Çoker M; Bayraktar BT; Gunduz M; Kiykim E; Olgac A; Pérez-Tur J; Rubio V; Häberle J
    Mol Genet Metab; 2014 Dec; 113(4):267-73. PubMed ID: 25410056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism.
    Wang Y; Chang L; Zhai J; Wu Q; Wang D; Wang Y
    J Cell Mol Med; 2017 Dec; 21(12):3214-3223. PubMed ID: 28557353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of carbamoyl-phosphate synthetase (CPS1) deficiency using human recombinant CPS1 as a key tool.
    Diez-Fernandez C; Martínez AI; Pekkala S; Barcelona B; Pérez-Arellano I; Guadalajara AM; Summar M; Cervera J; Rubio V
    Hum Mutat; 2013 Aug; 34(8):1149-59. PubMed ID: 23649895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of the carbamoyl phosphate synthase 1 promoter in human liver-derived cells is dependent on hepatocyte nuclear factor 3-beta.
    Chen Z; Tang N; Wang X; Chen Y
    J Cell Mol Med; 2017 Sep; 21(9):2036-2045. PubMed ID: 28272778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Molecule Inhibition of CPS1 Activity through an Allosteric Pocket.
    Yao S; Nguyen TV; Rolfe A; Agrawal AA; Ke J; Peng S; Colombo F; Yu S; Bouchard P; Wu J; Huang KC; Bao X; Omoto K; Selvaraj A; Yu L; Ioannidis S; Vaillancourt FH; Zhu P; Larsen NA; Bolduc DM
    Cell Chem Biol; 2020 Mar; 27(3):259-268.e5. PubMed ID: 32017919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamoyl phosphate synthetase-1 is a rapid turnover biomarker in mouse and human acute liver injury.
    Weerasinghe SV; Jang YJ; Fontana RJ; Omary MB
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G355-64. PubMed ID: 24924744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.